Big pharma, Biotech, Partnering

Novartis seals biotech deals with Regenerex to enhance kidney transplants

Posted on 09 September 2013

Tags: , , ,

Novartis, big pharma company, seals biotech deals by collaborating with Regenerex gaining access to stem cell technology that may help kidney transplant patients avoid taking anti-rejection medicine for life.

The technology may also be used in a number of inherited metabolic diseases with high unmet need such as sickle cell disease or metachromatic leukodystrophy.

Regenerex’s technology allowed five of eight kidney transplant patients to stop taking about a dozen pills a day to suppress their immune systems, according to research published last year.

The pills, which prevent rejection and stop tissue from a donated kidney from attacking the patient, can damage the transplant and cause diabetes, infections, heart disease and cancer.

The technology may also be used in a number of inherited metabolic diseases with high unmet need such as sickle cell disease or metachromatic leukodystrophy.

For further deal information visit Current Agreements (subscription required)

Related

Read: more on Novartis company profile, recent partnering, M&A and financing news and articles

Report: Partnering Deals and Alliances with Big Pharma

Report: Partnering Deals and Alliances with Novartis

Report: Regenerative Medicine and Stem Cells Partnering Terms and Agreements

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter – reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply

 

cabannerad300x150new4gif
rauconbadgejpg
e78banner300x150animgif
cabannerad300x150new4gif
e79banner300x150gif
e78banner300x150animgif